CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 80 filers reported holding CTI BIOPHARMA CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $14,000 | -58.8% | 26,979 | 0.0% | 0.00% | – |
Q4 2015 | $34,000 | -12.8% | 26,979 | 0.0% | 0.00% | – |
Q3 2015 | $39,000 | -26.4% | 26,979 | 0.0% | 0.00% | – |
Q2 2015 | $53,000 | +3.9% | 26,979 | 0.0% | 0.00% | – |
Q1 2015 | $51,000 | -20.3% | 26,979 | 0.0% | 0.00% | – |
Q4 2014 | $64,000 | -4.5% | 26,979 | 0.0% | 0.00% | – |
Q3 2014 | $67,000 | – | 26,979 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 10,698,618 | $13,159,000 | 15.42% |
BVF INC/IL | 43,795,613 | $53,869,000 | 9.18% |
DAFNA Capital Management LLC | 3,195,381 | $3,930,000 | 3.50% |
Sio Capital Management, LLC | 5,292,262 | $6,509,000 | 2.88% |
NEXTHERA CAPITAL LP | 656,000 | $807,000 | 1.14% |
Lombard Odier Asset Management (USA) Corp | 1,357,456 | $1,670,000 | 0.16% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,236,832 | $2,751,000 | 0.11% |
Consonance Capital Management LP | 510,000 | $635,000 | 0.08% |
Candriam S.C.A. | 1,515,000 | $1,863,000 | 0.05% |
SABBY MANAGEMENT, LLC | 575,669 | $708,000 | 0.04% |